Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

I have a special interest in Alzheimer’s disease. For nearly 25 years, I practiced general neurology in Portland, Oregon, and ...

SCIENTISTS investigating Alzheimer’s disease have made a key breakthrough, identifying a key cellular process that drives ...

Researchers challenge everything we know about Alzheimer's disease with shocking new findings about amyloid beta protein's ...

While nearly 7 million Americans aged 65 and older suffer from Alzheimer's disease, experts are reflecting on the advances in ...

Hints that the removal of amyloid plaques — which are a defining feature of Alzheimer's disease — may not be essential for improving cognition, could have implications for future treatments.

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...

The era of targeting these proteins at an early stage to minimise risk of Alzheimer’s progressing has started. The prospect ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease ... Points to New Treatments Nov.

“We pinpointed a novel neurodegenerative microglia phenotype in Alzheimer’s disease characterised ... to make sure that only the best and safest treatments are tested on humans in clinical ...

Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment of Early Alzheimer’s Disease: Results from the ...